FDA Adverse Event Malfunction Summary report: N

LACTATE DEHYDROGENASE (LDH)

MDR report key: 12745826 · Received November 3, 2021

Report

Report Number
3002809144-2021-00630
Event Type
Malfunction
Date Received
November 3, 2021
Date of Event
October 16, 2021
Report Date
November 29, 2021
Manufacturer
ABBOTT GMBH
Product Code
CFJ
UDI-DI
00380740161460
PMA / PMN Number
EXEMPT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

AN INVESTIGATION WAS PERFORMED FOR LACTATE DEHYDROGENASE (LDH) LIST NUMBER 2P56-22 LOT 44858UN21. A REVIEW OF TICKETS WAS PERFORMED AND FOUND NO OTHER TICKETS WITH THE SAME ERRATIC RESULTS ISSUE FOR THE REAGENT LOT. A REVIEW OF TRACKING AND TRENDING DID NOT IDENTIFY ANY TRENDS FOR THE COMPLAINT ISSUE. RETURN TESTING WAS NOT COMPLETED AS RETURNS WERE NOT AVAILABLE. A REVIEW OF THE MANUFACTURING DOCUMENTATION DID NOT IDENTIFY ANY ISSUES ASSOCIATED WITH THE COMPLAINT ISSUE. A REVIEW OF LABELING CONCLUDED THAT THE ISSUE IS SUFFICIENTLY ADDRESSED. BASED ON THE INVESTIGATION NO SYSTEMIC ISSUE OR DEFICIENCY OF THE LACTATE DEHYDROGENASE (LDH) LIST NUMBER 2P56-22 LOT 44858UN21 WAS IDENTIFIED.

Additional Manufacturer Narrative · 0

NO IDENTIFIER OR PATIENT DEMOGRAPHIC INFORMATION WAS PROVIDED. AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.

Description of Event or Problem · 0

THE CUSTOMER IDENTIFIED FALSELY ELEVATED LACTATE DEHYDROGENASE RESULTS. THE CUSTOMER USES THE REFERENCE RANGE 125U/L TO 243 U/L. THE FOLLOWING INFORMATION WAS PROVIDED: SAMPLE 1 INITIAL RESULT 218 U/L, REPEATED 349 U/L. SAMPLE 2 INITIAL RESULT 606 U/L, REPEATED 838 U/L. THE CUSTOMER NOTED THAT THE INITIAL RESULTS WERE REPORTED TO THE PHYSICIAN AND HAVE NOT BEEN QUESTIONED. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1643528 LACTATE DEHYDROGENASE (LDH) NAD REDUCTION/NADH OXIDATION, LACTATE DEHYDROGENASE CFJ ABBOTT GMBH 2P56-22 44858UN21 00380740161460

Patients

Seq Age Sex Outcome Treatment
1 Unknown ARC C8 PROC MOD, 01G06-11, C803721| ARC C8 PROC MOD, 01G06-11, C803721